Regarding "Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system".
Gorelick
David A
DA
D000428:Alcohol Drinking / Q000517:prevention & control* / Q000523:psychology; D002047:Buprenorphine / Q000494:pharmacology* / Q000627:therapeutic use; D019970:Cocaine-Related Disorders / Q000188:drug therapy; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D009292:Narcotic Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D009714:Nucleus Accumbens / Q000187:drug effects / Q000378:metabolism; D018847:Opioid Peptides / Q000494:pharmacology / Q000627:therapeutic use; D011957:Receptors, Opioid / Q000819:agonists / Q000187:drug effects* / Q000502:physiology; D000094942:Nociceptin Receptor; D000097629:Nociceptin
D002047:Buprenorphine; D004298:Dopamine; D009292:Narcotic Antagonists; D018847:Opioid Peptides; D011957:Receptors, Opioid; D000094942:Nociceptin Receptor; D000097629:Nociceptin; C000722283:OPRL1 protein, human